Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

Florence Duffaud, Antoîne Italiano, Emannuelle Bompas, María Rios, Nicolas Penel, Olivier Mir, Sophie Piperno‐Neumann, Christine Chevreau, Corinne Delcambre, François Bertucci, Pascaline Boudou‐Rouquette, Mathilde Cancel, Christophe Perrin, Esma Saâda-Bouzid, Laure Monard, Camille Schiffler, L. Chaigneau, Alice Hervieu, Olivier Collard, Corinne Bouvier, Vincent Vidal, Sylvie Chabaud, Jean‐Yves Blay